PDCD1 and neoplasm: To further confirm the combination effect of DDK inhibition and PD-1 blockade, we analyzed xenograft tissues by an IHC assay and found markedly increased abundance of tumor-infiltrated CD8+ T cells and granzyme B expression while decreased PD-1 expression in the combination therapy group (Figure 7j and Figure S10d).